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Abstract 
Purpose: To investigate the protective role of genistein against ischemic reperfusion (I/R) injury in rat 
kidneys.  
Methods: Group I (control, n = 10) consisted of animals that were not operated on while group II (sham, 
n = 10) were animals surgically operated on, similar to I/R group without renal bilateral ischemia. Group 
III (genistein, n = 10) consisted of animals administered 10 mg/kg genistein by oral gavage for 7 
consecutive days while group IV (I/R, n = 10) animals were subjected to 45 min of renal bilateral 
ischemia followed by 24 h of reperfusion. Group V (genistein+I/R, n = 10) received 10 mg/kg genistein 
by oral gavage for 7 consecutive days and then subjected to 45 min of renal bilateral ischemia followed 
by 24 h of reperfusion.  Renal function, total oxidant capacity and total antioxidant status in serum were 
evaluated in the rats. Further, reactive oxygen species generation as well as levels of protein carbonyl, 
lipid peroxidation, and enzymatic and non-enzymatic antioxidants were determined. Nrf-2 (nuclear factor 
(erythroid-derived 2)-like 2) and HO-1 (Heme oxygenase-1) expressions were determined by western 
blot.  
Results: Pre-treatment with genistein (10 mg/kg) significantly (p < 0.001) ameliorated I/R induced renal 
damage by reducing the levels of serum markers. Genistein pre-treatment significantly decreased (p < 
0.001) I/R injury induced-ROS, lipid peroxides and protein carbonyl content (p < 0.001). I/R injury 
significantly (p < 0.001) decreased non-enzymatic and enzymatic antioxidant activities. Genistein pre-
treatment also prevented renal I/R injury by significantly up-regulating Nrf-2, HO-1 expressions and 
antioxidant status.  
Conclusion: Thus, genistein may be therapeutically useful against kidney I/R injury by improving 
antioxidant defense mechanisms. 
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Renal ischemia/reperfusion injury (IRI) causes 
kidney dysfunction with increased mortality rate 
[1]. Oxygen impairment and subsequent 
accumulation of waste products initiates tissue 
damage [1,2]. Reperfusion causes increased free 
radical production ultimately leading to cellular 
death through apoptosis/necrosis [3]. Oxidative 
stress and decline in antioxidant balance are 
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central regulatory mechanism in the 
pathogenesis of renal I/R injury [4]. Pre-
conditioning offers protective effect against I/R 
injury and pre-treatment with pharmacological 
agents might be a possible therapeutic option 
against renal I/R injury [5].  
 
Genistein, a plant derived isoflavone has potent 
anti-oxidative property and offers numerous 
health benefits including cardioprotection, anti-
inflammatory and anti-cancer effects [6,7]. In the 
present study, we aimed at investigating whether 
genistein could offer protection against renal 
ischemic reperfusion injury by regulating 




Animals and study design 
 
All the animals and protocols used in the present 
study were followed according to National 
Research Council for Animal Care [8] and 
approved by the Ethical Committee (no. NR 
016/2014) of Shandong Provincial Hospital 
affiliated to Shandong University, China, prior to 
the commencement of the study. Fifty Male 
Wistar rats (age of 8 - 10 weeks) weighing 180 - 
220 g housed under standard conditions. The 
rats were maintained under controlled conditions 
of (21 ± 2 ºC) and relative humidity (65 - 70 %) 
with alternating 12 h dark and light cycle.  The 
animals were provided with ad libitum standard 
laboratory diet and water. After acclimatization, 
animals were divided randomly into 5 groups with 
ten animals per group. Genistein and all other 
chemicals used in the study were purchased 




Group I (control, n = 10) consisted of animals 
that were not operated on while group II (sham, n 
= 10) were animals surgically operated on, 
similar to I/R group without renal bilateral 
ischemia. This was followed by midline 
laparotomy; the kidneys were located and the 
renal pedicles with artery, vein and nerve supply 
were subjected to bilateral ischemia for 45 min. 
Group III (genistein, n = 10) consisted of animals 
administered 10 mg/kg genistein by oral gavage 
for 7 consecutive days while group IV (I/R, n = 
10) animals were subjected to 45 min of renal 
bilateral ischemia followed by 24 h of 
reperfusion. Group V (genistein+I/R, n = 10) 
received 10 mg/kg genistein by oral gavage for 7 
consecutive days and then subjected to 45 min 
of renal bilateral ischemia followed by 24 h of 
reperfusion. At the end of treatment period, the 
animals were fasted for 12 h, and anaesthetized 
with xylazine (10 mg/kg) and ketamine (100 
mg/kg). Heating lamp was used to maintain body 
temperature (37.5 ºC). Abdominal region was 
sterilized with povidine iodine solution and both 
the kidneys were isolated by midline incision 
procedure. The abdomen was closed in the 
sham group alone. In I/R and genistein + I/R 
administered groups, non-traumatic 
microvascular clamps were used to occlude renal 
arteries for 45 min. After 45 min, the clamps were 
removed blood flow was restored to the kidney 
and the incision closed.  
 
After 24 h reperfusion, the animals were 
anesthetized and blood was collected by cardiac 
puncture and the separated serum used for 
serum biomarker analysis. Nephrectomy was 
performed and the isolated kidney used for 
biochemical and molecular studies.  
 
Assessment of renal function markers 
 
Serum urea nitrogen was determined as 
described previously [9]. To 0.1 ml of serum, 3.3 
ml of double-distilled water, 0.3 ml of 10 % 
sodium tungstate and 0.3 ml of 0.67 N sulfuric 
acid were added. The samples were centrifuged 
at 4000 rpm, 15 min). To the supernatant, 1 ml of 
double-distilled water, 0.4 ml of diacetyl 
monoxime reagent and 0.6 ml of sulfuric acid-
phosphoric acid mixture were added and in a 
boiling water bath for 30 min. The samples were 
cooled to room temperature and the absorbance 
was read at 480 nm in a Shimadzu UV - 1700 
spectrophotometer.  Creatinine was estimated 
using the method described previously [10].  To 
1.0 ml of serum 8.0 ml of double-distilled water, 
0.5 ml of 2/3 N sulfuric acid and 0.5 ml of 10 % 
sodium tungstate were added and centrifuged 
(4000 rpm, 15 min). To 5.0 ml of the clear 
supernatant, 1.5 ml of saturated picric acid and 
1.5 ml of 0.75 N sodium hydroxide were added 
and incubated for 15 mins. The absorbance was 
read at 460 nm in Shimadzu UV - 1700 
spectrophotometer.  
 
Evaluation of serum total antioxidant capacity 
(TAC) and total oxidant status (TOS)  
 
Serum TAC levels were determined using a 
novel automated measurement method [11]. The 
hydroxyl radical produced through free radical 
reactions is directly proportional to the 
antioxidant levels in the serum. The results are 
expressed as μmol Trolox Eq/L. Serum TOS 
values were determined as described previously 
[12]. The colour intensity is directly proportional 
to the oxidant molecules in the serum. The assay 
is calibrated with hydrogen peroxide (H2O2) and 
the results are expressed in terms of micromolar 
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hydrogen peroxide equivalent per litre (μmol 
H2O2 Eq/L). 
 
Measurement of oxidative stress and 
antioxidant status 
 
The tissues were homogenized using ice-cold 50 
mM Tris-HCl buffer (pH 7.4) and centrifuged at 
3,000 rpm for 15 min (KUBOTA, KR-20000T). 
The supernatant was aliquoted and stored at - 20 
ºC for further analysis. Protein estimation was 
performed as described previously [13]. 
 
Determination of reactive oxygen species  
 
The levels ROS was determined as described 
previously [14]. To the kidney homogenate 
added 5 mM potassium phosphate buffer (pH 
7.4) and 2',7' -dichlorofluorescein diacetate DCF-
DA (10 µM), incubated at 37 ºC for 15 min 
followed by centrifugation (10,000 rpm, 10 min). 
The pellet suspended in phosphate buffered 
saline was incubated for 60 min at 37 ºC. 
Fluorescence intensity was measured at 
excitation (485 nm) and emission (528 nm) in a 
spectrofluorometer (Thermo Scientific, Waltham, 
MA). The results were expressed in percentage 
ROS generation was computed relative to control 
value and expressed as percentage. 
 
Determination of tissue protein carbonyl 
content (PCC) 
 
Tissue protein carbonyl content was determined 
as described previously [15]. The samples were 
treated with 10 mM DNPH in 2 M HCl and 
incubated at room temperature for 1 hr (shaking). 
The hydrazone derivatives were precipitated with 
20 % trichloroacetic acid and then was treated 
with ethanol/ethyl acetate, 1:1  to remove excess 
DNPH, and then re-precipitated with 10 % 
trichloroacetic acid. The pellet was dissolved in 
6 M guanidine hydrochloride. The absorbance 
was measured at 370 nm (Shimadzu UV - 1700 
spectrophotometer). The results were calculated 
as nmole of DNPH incorporated/mg of protein. 
The results were expressed as nanomoles of 
carbonyl/mg of protein. 
 
Lipid peroxidation assay 
 
Thiobarbituric acid reactive species (TBARS) 
content was determined as described previously 
[16]. To the 0.1 ml homogenate added, 200 μl of 
butylated hydroxytoluene (BHT) in methanol, 200 
μl 1M phosphoric acid and 350 μl of TBA 
(Thiobarbituric acid) solution. The tubes were 
mixed vigorously and incubated for 60 min at 60 
°C.  The mixture was centrifuged at 10,000g for 
10 mins. The supernatant was read at 532 nm. 
The amount of TBARS formed was calculated 
using extinction coefficient, E = 1.56 x 105). The 
results are expressed as thiobarbituric acid 
reactants formed/mg of protein. 
 
Evaluation of antioxidant enzyme activities  
 
Glutathione (GSH)  
 
The samples were precipitated with using TCA 
and centrifuged at 6000 g for 15 mins. The 
supernatant was treated with DTNB (5,5′-
dithiobis- (2-nitrobenzoic acid), where the –SH 
group of GSH reacts with DTNB and the yellow 
coloured product was measured at 405 nm. The 
GSH content was determined using the standard 
GSH concentration. The results were expressed 
as Units/mg of protein. 1U = nmoles of GSH/mg 
of protein. 
 
Superoxide dismutase (SOD) activity 
 
The SOD activity was determined as described 
[17]. To 0.1 ml of homogenate, added 50 mM 
Tris-cacodylic acid buffer (pH 8.2), and pyrogallol 
solution (0.2 mM) and EDTA (1 mM). Followed 
by which the reading was measured for 3 mins 
(30 sec interval). The method measures the 
auto-oxidation of pyrogallol and 1 unit = the 
amount of enzyme required to inhibit pyrogallol 
auto-oxidation by 50 %. 
 
Glutathione-S-Transferase (GST) activity 
 
The reaction mixture contained 0.1 ml of 
homogenate in 0.1 M phosphate buffer (pH 6.5), 
1 mM 1-chloro-2, 4-dinitrobenzene (CDNB), and 
1 mM GSH in a final volume of 3 ml. Followed by 
which the reading was measured for 3 mins (30 
sec interval). The enzyme activity was 
determined using extinction coefficient of GS-
CDNB, E340 = 0.0096 μM− 1 cm− 1 and expressed 
as Units/mg of protein. 1U = nmoles of CDNB 
conjugated/min/mg protein [18]. 
 
Glutathione peroxidase (GPx) activity 
 
GPx was performed as described by [19]. To 0.1 
ml of homogenate in 50 mM phosphate buffer pH 
7.0, added 0.5 ml sodium azide (0.1 mM), 1ml 
glutathione (0.5 mM), 1.2 ml hydrogen peroxide 
(1 mM). To the above reaction mixture added 
0.5 ml of 10 % TCA and incubated for 5 mins at 
37 °C and centrifuged at 5000 rpm for 15 mins. 
To the supernatant (0.1ml), added 5,5′-Dithio-bis 
(2-nitrobenzoic acid) (DTNB) and the read at 412 
nm. 1U = 1 μ mole GSH to GSSG in the 
presence of H2O2/min. The enzyme activity was 
expressed as units/mg protein.  
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Catalase (CAT) activity 
 
The activity was determined according to the 
method described by [20]. To 0.1 ml of tissue 
homogenate added, 50 mM, phosphate buffer, 
pH 7.0.  1.0 ml of 10 mM H2O2 was added and 
the reading was measured for 3 mins (30 sec 
interval) at 240 nm. The enzyme activity was 
determined using extinction coefficient of H2O2 
(E240 = 43.6 M− 1 cm− 1) and expressed as 
Units/mg of protein. 1U = μM of 
H2O2 utilized/min/mg protein. 
 
Western blot analysis 
 
The tissues were homogenized and nuclear and 
cytoplasmic extract were isolated from CelLytic 
Nuclear Extraction kit. The protein isolated was 
loaded in 12 % SDS-PAGE gels and the 
separated proteins were transferred into NC 
(nitrocellulose) membrane. The membrane was 
incubated with primary and secondary antibodies 
for Nrf-2 and HO-1 proteins and developed with 
super signal ECL kit. The bands were developed 




The data were analyzed using one-way analysis 
of variance (ANOVA) followed by Tukey’s 
multiple comparison test using SPSS version 
10.0). The level of significance was set variously 




Renal I/R injury caused significant increase (p < 
0.001) in serum kidney markers urea and 
creatinine when compared to control rats. Sham 
rats and Genistein treated rats showed non-
significant difference in serum biomarkers when 
compared to control group. Treatment with 
Genistein followed by I/R restored the kidney 
function by reducing renal markers (p < 0.001) 
compared to I/R rats (Fig1A and 1B). I/R rats 
showed significant increase (p<0.001) in TOS 
levels with concomitant decrease (p < 0.01) in 
TAC levels compared to control group. However, 
in rats pre-treated with genistein followed by I/R 
injury showed significant decrease (p < 0.001) in 
TOS levels with concomitant increase (p < 0.01) 




Figure 1: Genistein on renal biomarkers during I/R 
injury. Serum creatinine (A) and serum urea (B) levels 
in renal I/R injury rats pre-treated with genistein. 
Group I (control); Group II (sham): Group III 
(genistein): Group IV (I/R): Group V (genistein + I/R). 
Results are given as the mean ± SEM for 10 rats in 
each group; ***p < 0.001, when compared to control; 
###p < 0.001, when compared to I/R group 
 
Genistein ameliorates I/R injury  
 
Rats with I/R injury showed a significant increase 
(p < 0.001) in the levels of lipid peroxides (Figure 
2), protein carbonyl content (Figure 3) and 
reactive oxygen species (Figure 4) when 
compared to control rats. These levels were 
significantly decreased (p < 0.001) in rats treated 
with genistein followed by I/R injury. Rats treated 
with genistein/sham-operated rats showed non-
significant levels of oxidative markers when 
compared to control group. 
 
Table 1: Effect of genistein on total antioxidant capacity (TAC) and total oxidant status (TOS) in ischemic 
reperfusion injury in rat kidneys 
 
Parameter Group I Group II Group III Group IV Group V 
TAC 3.12±0.01 3.15±0.01NS 3.67±0.01 NS 1.17±0.01*** 2.98±0.01### 
TOS 34±2.0 32±2.21 NS 34.1±2.01 NS 47±2.76** 32±2.98## 
Group I (control); Group II (Sham):  Group III (Genistein): Group IV (I/R): Group V (genistein + I/R). Results are 
given as the mean ± SEM for 10 rats in each group. ***p < 0.001, **p< 0.01when compared to control. 
###p<0.001, ##p<0.01when compared to I/R group. NS, Not Significant when compared to control (One way 
ANOVA followed by Tukey’s multiple comparison). TAC is expressed as μmol Trolox Eq/L; TOS is expressed as 
μmol H2O2 Eq/L 
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Figure 2: Effect of genistein on lipid peroxide levels in 
renal I/R injury. The results are expressed as 
nanomoles of TBA reactants formed/mg of protein. 
Group I (control); Group II (sham):  Group III 
(genistein): Group IV (I/R): Group V (genistein + I/R). 
Results are given as the mean ± SEM for 10 rats in 
each group; ***p<0.001, when compared to control; 
###p < 0.001, when compared to I/R group; NS = not 




Figure 3: Effect of genistein on protein carbonyl 
content. The results are expressed as protein carbonyl 
content (nM)/mg of protein. Group I (control); Group II 
(sham):  Group III (genistein): Group IV (I/R): Group V 
(genistein + I/R). Results are given as the mean ± 
SEM for 10 rats in each group; ***p< 0.001, when 
compared to control; ###p < 0.001, when compared to 





Figure 4: Effect of genistein on reactive oxygen 
species content in I/R rats. The results are expressed 
as % ROS generation compared to control (100 %). 
Group I (control); Group II (sham):  Group III 
(genistein): Group IV (I/R): Group V (genistein + I/R). 
Results are given as the mean ± SEM for 10 rats in 
each group. ***p<0.001, when compared to control; 
###p< 0.001, when compared to I/R group; NS = not 
significant when compared to control  
 
Genistein prevents renal I/R injury  
 
The levels of GSH found to be significantly 
decreased (p < 0.001) in I/R rats when compared 
to control group. Genistein treatment increased 
the GSH levels in a significant manner (p < 
0.001) when compared to I/R alone treated rats 
(Table 2). The activities of enzymatic 
antioxidants (SOD, CAT, GST and GPx) were 
significantly declined when compared to control 
group. These antioxidant enzyme activities were 
significantly increased in rats treated with 
genistein followed by I/R injury. There was a non-
significant difference in the antioxidant activities 
in sham rats and Genistein treated rats when 
compared to control group (Table 2). 
 
Table 2: Effect of genistein on antioxidant status of rats with renal I/R injury 
 
 Parameter      Group I Group II Group III Group IV Group V 
GSH (nM/mg 
of protein) 
   41.00±2.90 41±1.98 NS 43.50±1.76 NS 19.00±2.51*** 37.00±2.43 ## 
SOD (U/mg 
of protein) 
   156.00±1.20 154±2.13 NS 153.00±2.49 NS 128.00±2.08*** 132.00±2.81### 
CAT  (U/mg 
of protein) 
   1.44±0.01   1.28±0.01 NS 1.41±0.02NS 0.52±0.02** 1.02±0.01## 
GPX (U/mg 
of protein) 
2.32±0.01     2.96±0.01 NS 2.41±0.02 NS 1.29±0.01** 1.62±0.01### 
GST (U/mg of 
protein) 
  36.00±1.23 37.00±1.90 NS 35.00±1.56 NS 23.00±1.01 ** 31±1.65 ### 
Group I (control); Group II (sham):  Group III (genistein): Group IV (I/R): Group V (genistein + I/R). Results are 
given as the mean ± SEM (n = 10); ***p < 0.001, **p < 0.01when compared to control. ##p<0.05, ###p< 0.001, 
when compared to I/R group. NS = not significant when compared to control; GSH in nanomoles of GSH/mg of 
protein; SOD, CAT, GPx and GST activities in Units/mg protein 
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Figure 5: Genistein up regulates Nrf-2 and HO-1 expressions. A = nuclear expression of Nrf-2; GAPDH was 
used as internal control; B = Densitometric analysis of Nuclear Nrf-2 expression; C = Cytoplasmic expression of 
Nrf-2 and HO-1; D = Densitometric analysis of Nrf-2 and HO-1 expression; ***p < 0.001, when compared to 
control; ###p<0.001, when compared to I/R group; NS = not significant when compared to control 
 
Genistein pre-treatment induces Nrf-2/HO-1 
expression during I/R injury 
 
In order to determine whether protective effect of 
genistein is mediated by nrf-2 signaling we 
analyzed the expressions Nrf-2 and HO-1 in the 
wistar rats. Figure 5 shows that I/R injury caused 
significant decrease of Nrf-2 levels in the nucleus 
however treatment with genistein followed by I/R 
injury increased nuclear Nrf-2 expressions. 
Further, HO-1 expression was significantly down 
regulated during I/R injury, while pre-treatment 
with genistein increased the HO-1 expressions 




The present study shows that genistein 
significantly offered cytoprotection against renal 
ischemic reperfusion injury in wistar rats. The 
increased level of serum markers (urea and 
creatinine) during I/R injury demonstrates severe 
damage to the renal tissue. These levels were 
markedly reduced during genistein treatment in 
rats with I/R injury. Further, genistein exerted 
protective effect by increasing the antioxidant 
capacity with concomitant decline in total oxidant 
status. Similar protective effect offered by 
genistein against renal damage by decreasing 
the serum urea and creatinine levels has been 
reported earlier [21]. 
 
Over production of ROS leads to oxidative stress 
conditions, which ultimately results in tissue 
injury. One of the most sensitive organs for 
oxidative stress includes kidney and the present 
study showed a significant increase in the levels 
of reactive oxygen species during renal I/R injury. 
Intracellular reactive oxygen species include 
species such as hydrogen peroxide (H2O2), 
hypochlorous acid (HClO), superoxide anion (O2-
). Any imbalance in these levels leads to rise in 
ROS levels, which results in damage to DNA, 
lipid and proteins. Reactive species interact with 
unsaturated bonds in lipid moieties and leads to 
the formation of lipid peroxides [22]. These 
species also result in oxidation of proteins and 
ultimately results in the formation of protein 
carbonyls. The stable moieties are measured 
biochemically, which acts as an important 
biomarker in protein damage [23]. The present 
studies showed a significant increase in lipid 
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peroxide levels and protein carbonyl content 
during I/R injury. A significant accumulation of 
MDA and protein carbonyls during I/R injury was 
ameliorated during genistein treatment. 
Additionally, Genistein treatment during ischemic 
reperfusion injury reduced reactive oxygen 
species generation, thus it might be the reason 
for its preventive effects against various 
downstream events against I/R induced oxidative 
stress. The antioxidant property of genistein 
against the amelioration oxidative stress status 
through inhibition of lipid peroxidation and ROS 
generation has been documented earlier [24]. 
 
It has been well documented that antioxidant 
defense mechanisms play a crucial role in 
protecting against various diseased conditions, 
which is primarily mediated through oxidative 
stress. Various phase II cytoprotective enzymes 
such as SOD, CAT, GST and GPx are involved 
in protective role. GSH is an important non-
protein thiol, which is endogenous in nature, acts 
as a first defense against oxidative stress 
conditions [25]. Enzymatic antioxidants act in 
coherence in the efficient removal of toxic 
species from the cell. Superoxide dismutase 
reacts with superoxides and results in the 
formation of hydroxyl radicals. Catalase reacts 
with the hydroxyl radicals and forms H2O and O2 
[26]. GSH in conjugation with GPx offers 
protection from various toxic metabolites [27]. 
The present study shows that I/R injury lead to 
decrease in levels of GSH content and enzymatic 
antioxidants (superoxide dismutase, catalase, 
glutathione peroxidase and glutathione-S-
transferase). However, genistein treatment 
followed by I/R injury showed a significant 
increase in both enzymatic and non-enzymatic 
antioxidant status. Further, we also demonstrate 
here that Genistein induced protection against 
I/R injury was mediated through Nrf-2/HO-1 
signaling mechanisms. Nrf-2 (nuclear factor 
erythroid 2-related factor 2) is a nuclear 
transcription factor and well established as 
oxidative stress regulator. Under normal and 
oxidative stress conditions, Nrf-2 controls the 
antioxidant defense mechanisms. Nrf-2 
translocates into nucleus and binds to antioxidant 
response elements (ARE)- and induces 
expression of HO-1, GCL, NQO1 [28]. Genistein 
induced improved antioxidant enzyme activities 
have been reported earlier and the mechanism of 
protection has been linked with up-regulation of 




The findings of the present study show clear 
evidence that genistein treatment offers 
significant protective effect against renal 
ischemic reperfusion injury in rats by reducing 
renal damage and oxidative stress with 
concomitant increase in antioxdative defense 
mechanisms. Thus, nutritional intervention with 
genistein may be a promising strategy against 
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